These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15765)

  • 1. [Study on the interactions between ditazol and anticoagulants in patients with intracardiac valvular prostheses].
    Jacovella G; Milazzotto F
    Clin Ter; 1977 Mar; 80(5):425-31. PubMed ID: 15765
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time.
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1277-83. PubMed ID: 4801220
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Usefulness of long-term and short-term use of coumarinic anticoagulants in patients with intracardiac valvular prosthesis. Comparative study"].
    Escudero J; Díaz Devis C; Palacios Macedo X
    Arch Inst Cardiol Mex; 1968; 38(4):525-32. PubMed ID: 5685450
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions].
    Nasu M; Shikano K; Miyamura K; Shinpo H; Morimoto T; Ohi T; Shomura S; Yamazaki N; Yada I; Kusagawa M
    Kyobu Geka; 1983 Sep; 36(9):701-5. PubMed ID: 6632428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulants in therapy of patients with heart valve prostheses].
    Mauro R; Calatola P
    Minerva Med; 1975 Apr; 66(25):1229-35. PubMed ID: 1134663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 7. Acenocoumarol and 6-mercaptopurine: an important drug interaction.
    Fernández MA; Regadera A; Aznar J
    Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombogenicity of an artificial surface is decreased by the antiplatelet agent ditazol.
    Mari D; Cattaneo M; Gattinoni A; Dioguardi N
    Thromb Res; 1978 Jan; 12(1):59-66. PubMed ID: 25496
    [No Abstract]   [Full Text] [Related]  

  • 9. [The anticoagulant treatment of patients with heart valve prostheses].
    Cristodorescu R; Brânzan L; Szvantek C; Drăgulescu S; Anderca I; Streian C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):343-52. PubMed ID: 2573944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monitoring of anticoagulant treatment in patients with cardiac valvular prostheses].
    Arboix M; Clos F; Frati ME; Laporte JR
    Arch Farmacol Toxicol; 1983 Apr; 9(1):79-82. PubMed ID: 6625677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].
    Harmsze AM; Deneer VH; Wiltink EH
    Ned Tijdschr Geneeskd; 2007 Sep; 151(35):1945-9. PubMed ID: 17907547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of oxyphenbutazone on platelet adhesiveness in cholecystectomized patients.
    Kapp JP; Duckert F
    Helv Med Acta; 1973 Oct; 37(4):259-64. PubMed ID: 4763640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-thromboembolic therapy and effects of dipyridamole on platelet function in patients with heart valve prostheses (authors transl)].
    Tokumo M; Doko S; Ono Y; Takabatake T; Noguchi A; Omoto T; Teramoto S
    Kyobu Geka; 1978; 31(1):19-22. PubMed ID: 628105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Should all prosthetic valve patients be treated by platelet inhibitors?].
    Lévy G; Bordes F; Mariottini P; François G
    Nouv Presse Med; 1976 Jan; 5(5):251-4. PubMed ID: 1264682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plausible pharmacologic interaction between fosinopril and acenocoumarol].
    de Tomás ME; Sáez L; Beltrán S; Gato A
    Med Clin (Barc); 1997 May; 108(19):757. PubMed ID: 9324602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative effects of retabolyl and syncoumar on thrombocyte function].
    Savel'eva AV
    Farmakol Toksikol; 1973; 26(4):465-8. PubMed ID: 4789898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
    Boda Z; Voith L; Udvardy M; Hársfalvi J; Pfliegler G; Tornai I
    Orv Hetil; 1987 Feb; 128(5):239-42. PubMed ID: 3547248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic evaluation of a valve prosthesis in patients receiving anticoagulants].
    Augé JM; Fontcuberta J; Félez J; Oriol A; Crexells C
    Rev Esp Cardiol; 1987; 40(6):406-9. PubMed ID: 3454987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platelet activity in patients with ischemia of the lower limbs treated with acenocoumarol].
    Kowal-Gierczak B; Kotschy M; Kurzawska-Mielecka M; Plamieniak L
    Pol Tyg Lek; 1984 Oct; 39(44):1445-6. PubMed ID: 6514619
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between cyclosporine and acenocoumarol in a patient with nephrotic syndrome.
    Borrás-Blasco J; Enriquez R; Navarro-Ruiz A; Martinez-Ramirez M; Cabezuelo JB; Gonzalez-Delgado M
    Clin Nephrol; 2001 Apr; 55(4):338-40. PubMed ID: 11334326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.